Format

Send to

Choose Destination
Biochemistry (Mosc). 2012 Jun;77(6):666-70. doi: 10.1134/S0006297912060144.

Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss.

Author information

1
Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119991 Moscow, Russia.

Abstract

The influence of the mitochondria-targeted antioxidant SkQR1 on gentamycin-induced nephrotoxicity and ototoxicity has been analyzed. SkQR1 reduces the death of kidney epithelium cells and decreases the severity of renal failure caused by gentamycin application and also lowers the animals' mortality. Treatment with SkQR1 also decreases gentamycin-induced hearing loss. Mitochondria-targeted antioxidants, such as SkQR1, are new promising agents for preventing negative consequences of therapy with antibiotics.

PMID:
22817467
DOI:
10.1134/S0006297912060144
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Biochemistry (Moscow)
Loading ...
Support Center